Literature DB >> 22534152

Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus.

Julie De Buyst1, Thameur Rakza, Thomas Pennaforte, Anne-Britt Johansson, Laurent Storme.   

Abstract

OBJECTIVE: To determine the hemodynamic impact of fluid restriction in preterm newborns with significant patent ductus arteriosus. STUDY
DESIGN: Newborns ≥24 and <32 weeks' gestational age with significant patent ductus arteriosus were eligible for this prospective multicenter observational study. We recorded hemodynamic and Doppler echocardiographic variables before and 24 hours after fluid restriction.
RESULTS: Eighteen newborns were included (gestational age 24.8 ± 1.1 weeks, birth weight 850 ± 180 g). Fluid intake was decreased from 145 ± 15 to 108 ± 10 mL/kg/d. Respiratory variables, fraction of inspired oxygen, blood gas values, ductus arteriosus diameter, blood flow-velocities in ductus arteriosus, in the left pulmonary artery and in the ascending aorta, and the left atrial/aortic root ratio were unchanged after fluid restriction. Although systemic blood pressure did not change, blood flow in the superior vena cava decreased from 105 ± 40 to 61 ± 25 mL/kg/min (P < .001). The mean blood flow-velocity in the superior mesenteric artery was lower 24 hours after starting fluid restriction.
CONCLUSIONS: Our results do not support the hypothesis that fluid restriction has beneficial effects on pulmonary or systemic hemodynamics in preterm newborns.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22534152     DOI: 10.1016/j.jpeds.2012.03.012

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

1.  Acetaminophen to avoid surgical ligation in extremely low gestational age neonates with persistent hemodynamically significant patent ductus arteriosus.

Authors:  D E Weisz; F F Martins; L E Nield; A El-Khuffash; A Jain; P J McNamara
Journal:  J Perinatol       Date:  2016-04-07       Impact factor: 2.521

2.  Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.

Authors:  Ronald I Clyman; Melissa Liebowitz
Journal:  J Pediatr       Date:  2017-07-11       Impact factor: 4.406

Review 3.  The role of furosemide and fluid management for a hemodynamically significant patent ductus arteriosus in premature infants.

Authors:  Sarah Dudley; Shawn Sen; Alison Hanson; Afif El Khuffash; Philip T Levy
Journal:  J Perinatol       Date:  2022-07-15       Impact factor: 3.225

4.  Hospital variation in neonatal echocardiography among very preterm infants at US children's hospitals.

Authors:  Brian C King; Joseph Hagan; Troy Richardson; Jay Berry; Jonathan L Slaughter
Journal:  J Perinatol       Date:  2022-09-26       Impact factor: 3.225

5.  Trends in Patent Ductus Arteriosus Diagnosis and Management for Very Low Birth Weight Infants.

Authors:  Samantha Ngo; Jochen Profit; Jeffrey B Gould; Henry C Lee
Journal:  Pediatrics       Date:  2017-04       Impact factor: 7.124

Review 6.  Patent ductus arteriosus in preterm infants: do we have the right answers?

Authors:  Hesham Abdel-Hady; Nehad Nasef; Abd Elazeez Shabaan; Islam Nour
Journal:  Biomed Res Int       Date:  2013-12-23       Impact factor: 3.411

7.  Survey of PDA management in very low birth weight infants across Italy.

Authors:  Benjamim Ficial; Iuri Corsini; Stefano Fiocchi; Federico Schena; Irma Capolupo; Rosa Maria Cerbo; Manuela Condò; Daniela Doni; Simona La Placa; Salvatore Porzio; Katia Rossi; Sabrina Salvadori; Marilena Savoia
Journal:  Ital J Pediatr       Date:  2020-02-14       Impact factor: 2.638

8.  An Update on Patent Ductus Arteriosus and What is Coming Next.

Authors:  Ömer Erdeve; Emel Okulu; Yogen Singh; Richard Sindelar; Mehmet Yekta Oncel; Gianluca Terrin; Giovanni Boscarino; Ali Bülbül; Hannes Sallmon; Begüm Atasay; Fahri Ovalı; Ronald I Clyman
Journal:  Turk Arch Pediatr       Date:  2022-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.